<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T16:53:05Z</responseDate><request verb="GetRecord" identifier="oai:uwspace.uwaterloo.ca:10012/20487" metadataPrefix="dim">https://dspacemainprd01.lib.uwaterloo.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:uwspace.uwaterloo.ca:10012/20487</identifier><datestamp>2025-03-26T23:32:47Z</datestamp><setSpec>com_10012_9860</setSpec><setSpec>com_10012_1</setSpec><setSpec>col_10012_9862</setSpec><setSpec>col_10012_6</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Dominelli, Paolo</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" authority="d758c563-d37b-499c-b964-d8cd831570cb" confidence="600">Chang, Jou-Chung</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2024-04-24T17:14:39Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2024-04-24</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="submitted">2024-04-19</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/10012/20487</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en">Acute mountain sickness (AMS) can occur due to rapid altitude ascents and/or insufficient acclimatization. Acetazolamide (AZ) is commonly prescribed for AMS prophylaxis but appears to inhibit exercise performance. Methazolamide (MZ) has similar prophylactic benefits but does not have a similar decrement in isolated small muscle mass exercise in normoxia. We compared whole-body exercise performance in acute hypoxia (FIO2 = 0.15) between AZ and MZ and hypothesized that time trial duration will be the shortest in MZ compared with AZ and placebo (PLA). Fifteen young healthy participants completed 5 testing visits: day 1 maximal exercise test, day 2 a familiarization visit, and Day 3-5 were the experimental visits. Each experimental visit involved a 5-km hypoxic cycling time trial performed after a 2-day dosing protocol of either AZ (250mg t.i.d.), MZ (100mg b.i.d.) or PL (t.i.d.); the order was randomized and double-blinded. Before and after each experimental time trial, capillary blood samples were taken, and maximal voluntary contractions of the quadriceps were performed. AZ and MZ resulted in a partially compensated metabolic acidosis at rest (capillary H+ 47±3, 43±2, 39±2 nmol for AZ, MZ and PLA respectively, p&amp;lt;0.01). Time to complete 5-km on PLA (562±32s, p&amp;lt;0.01) was significantly faster than AZ and MZ (577±38 vs. 581±37s respectively), with no differences between AZ and MZ (p=0.96). The 5-km average ventilatory efficiency (V̇E/V̇CO2) listed from greatest to least was MZ, AZ and PLA (46±6, 43±4, 37±3 respectively) and were all significantly different (p&amp;lt;0.05). There were no differences in the average ventilation (124±27, 127±24, 127±19 L/min respectively) and oxyhemoglobin saturation (87±2, 88±2, 88±3 respectively) between PLA, AZ and MZ (p&amp;gt;0.05). Peak quadricep torque before exercise was found to be significantly lower in AZ compared to PLA and MZ (543± 77, 574± 76, 552± 67 N respectively, p&amp;lt;0.05). In conclusion, both AZ and MZ impaired whole-body exercise performance in acute hypoxia and this finding might be important to consider for high altitude occupations.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en">en</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en">University of Waterloo</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en">carbonic anhydrase inhibitor</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en">acetazolamide</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en">methazolamide</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en">exercise physiology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en">altitude physiology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en">time trial performance</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en">aerobic exercise</dim:field>
   <dim:field mdschema="dc" element="title" lang="en">The effects of carbonic anhydrase inhibitors on exercise performance in acute hypoxia</dim:field>
   <dim:field mdschema="dc" element="type" lang="en">Master Thesis</dim:field>
   <dim:field mdschema="dc" element="pending">false</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="department" lang="en">Kinesiology and Health Sciences</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="discipline" lang="en">Kinesiology</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="grantor" lang="en">University of Waterloo</dim:field>
   <dim:field mdschema="uws-etd" element="degree" lang="en">Master of Science</dim:field>
   <dim:field mdschema="uws-etd" element="embargo" qualifier="terms" lang="en">4 months</dim:field>
   <dim:field mdschema="uws-etd" element="embargo">2024-08-22T17:14:39Z</dim:field>
   <dim:field mdschema="uws" element="contributor" qualifier="advisor">Dominelli, Paolo</dim:field>
   <dim:field mdschema="uws" element="contributor" qualifier="affiliation1" lang="en">Faculty of Health</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="city" lang="en">Waterloo</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="country" lang="en">Canada</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="province" lang="en">Ontario</dim:field>
   <dim:field mdschema="uws" element="typeOfResource" lang="en">Text</dim:field>
   <dim:field mdschema="uws" element="peerReviewStatus" lang="en">Unreviewed</dim:field>
   <dim:field mdschema="uws" element="scholarLevel" lang="en">Graduate</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>